ArticlePDF Available

Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China

Authors:

Abstract and Figures

The relationship of oats and buckwheat intake to cardiovascular disease risk factors was studied in 850 Yi people, an ethnic minority in southwest China. Blood pressure was measured on 3 consecutive days. Serum total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglycerides were measured after a 14-h fast. Oats and buckwheat intakes were assessed by questionnaire. In multiple-regression analysis, oats intake (100 g/d) was associated with lower body mass index (-0.25, in kg/m2; P < 0.05), systolic (-3.1 mm Hg, P < 0.001) and diastolic (-1.3 mm Hg, P < 0.01) blood pressure, and HDL cholesterol (-0.13 mmol/L, P < 0.001). Buckwheat intake (100 g/d) was associated with lower serum total cholesterol (-0.07 mmol/L, P < 0.01) and low-density-lipoprotein cholesterol (-0.06 mmol/L, P < 0.05) and a higher ratio of HDL to total cholesterol (0.01, P < 0.05). These findings suggest a role for oats and buckwheat consumption in the prevention and treatment of both hypertension and hypercholesterolemia.
Content may be subject to copyright.
366 Am J C/in Nutr 1995;61:366-72. Printed in USA. © 1995 American Society for Clinical Nutrition
Oats and buckwheat intakes and cardiovascular disease
risk factors in an ethnic minority of China13
Jiang He, Michael J K/ag, Paul K Whelton, Jing-Ping Mo, Jun-Yun Chen, Ming-Chu Qian,
Pei-Sheng Mo, and Guan-Qing He
ABSTRACT The relationship of oats and buckwheat in-
take to cardiovascular disease risk factors was studied in 850
Yi people, an ethnic minority in southwest China. Blood pres-
sure was measured on 3 consecutive days. Serum total choles-
tenol, high-density-lipoprotein (HDL) cholesterol, and tniglyc-
enides were measured after a 14-h fast. Oats and buckwheat
intakes were assessed by questionnaire. In multiple-regression
analysis, oats intake (100 g/d) was associated with lower body
mass index (-0.25, in kg/m2; P < 0.05), systolic (-3.1 mm
Hg, P < 0.001) and diastolic (- 1.3 mm Hg, P < 0.01) blood
pressure, and HDL cholesterol (-0.13 mmol/L, P < 0.001).
Buckwheat intake (100 g/d) was associated with lower serum
total cholesterol (-0.07 mmol/L, P<0.01) and low-density-
lipoprotein cholesterol (-0.06 mmol/L, P < 0.05) and a higher
ratio of HDL to total cholesterol (0.01, P < 0.05). These
findings suggest a role for oats and buckwheat consumption in
the prevention and treatment of both hypertension and hypen-
cholesterolemia. Am J C/in Nutr 1995;61:366-72
KEY WORDS Oats, buckwheat, dietary fiber, blood pres-
sure, serum cholesterol
Introduction
Although mortality from cardiovascular disease has declined
progressively in the United States during the past three de-
cades, it is still the leading cause of death. In 1989 an estimated
944 688 US residents died of cardiovascular disease, almost as
many as from all other causes of death combined (1). In many
economically developing countries, including China, cardio-
vascular disease mortality has increased rapidly and has be-
come the leading cause of death (2).
Elevations of blood pressure (3-5) and serum cholesterol
(6-8) are widely recognized as major modifiable risk factors
for cardiovascular disease. In addition, pharmacologic therapy
of hypertension and hypenlipidemia has been well established
as a means to prevent cardiovascular disease (9-14). However,
it has also become increasingly apparent that altered quality of
life, medication toxicity, and costs of medical care limit the
usefulness of lifelong drug therapy for hypertension and hy-
perlipidemia (15). Lifestyle modifications, especially dietary
interventions, constitute an important and complementary ap-
proach to the therapy for hypertension and hyperlipidemia in
the individual (15, 16). Dietary interventions assume an even
more important role in the population-based approach to car-
diovascular disease risk reduction. Here, the goal is to achieve a
small downward shift in the population distribution of blood
pressure and cholesterol by altering environmental exposures (15).
Oats, a grain rich in water-soluble fiber, has been shown to
lower serum lipids in animal and human experiments. De Groot
et al (17) reported in 1963 that 21 male volunteers who ate 140
g rolled oats daily for 3 wk experienced a decrease in their
average serum cholesterol from 6.49 to 5.77 mmolfL. Since
then, most (18-30) but not all (31, 32) clinical trials have
demonstrated that intake of oats lowers serum cholesterol in
hyperlipidemic patients (18-26) as well as in healthy adults
(27-29) and children (30). The relationship between oats intake
and serum lipids has not been well studied in population-based
samples. In addition, the effect of buckwheat, another cereal
high in water-soluble fiber (33), on serum lipids and blood
pressure has not been established.
The present study investigated the relationship between oats
and buckwheat intakes and cardiovascular disease risk factors
in an ethnic minority in China-the Yi people.
Subjects and methods
Subjects
The Yi Migrant Study is a population-based epidemiologic
investigation of cardiovascular disease risk factors in the Li-
angshan Yi People Autonomous Prefecture in southwest China.
As part of this study, serum lipids and lipopnoteins, blood
pressure, body weight, dietary habits, physical activity, smok-
ing, and alcohol consumption were measured in 857 Yi men
randomly selected from the community. Details of the study
1From the Welch Center for Prevention, Epidemiology, and Clinical
Research, the Johns Hopkins University Medical Institutions, Baltimore; the
Department of Epidemiology, Peking Union Medical College and Chinese
Academy of Medical Sciences and the National Center for Clinical Labora-
tories, Beijing; and Liangshan Yi People Autonomous Prefecture Anti-epi-
demic Station, Xichang City, Sichuan Province, People’s Republic of China.
2Supported by the Ministry of Public Health, People’s Republic of
China; Outpatient General Research Center grant 5M01RR00722 from the
National Institutes of Health; the Quaker Oats Company; and National
Institutes of Health grant RR00035.
3Address reprint requests to J He, The Welch Center for Prevention,
Epidemiology, and Clinical Research, 2024 East Monument Street, Suite
2-600, Baltimore, MD 21205-2223.
Received April 5, 1994.
Accepted for publication August 29, 1994.
by guest on July 14, 2011www.ajcn.orgDownloaded from
OATS AND CARDIOVASCULAR DISEASE 367
population and methods have been described elsewhere (34).
Briefly, the Yi people are an ethnic minority of China who live
principally in a remote mountainous area in southwest China
and who are mainly engaged in subsistence agriculture. Yi
farmers are relatively isolated from the outside world and have
preserved their own language and life style. Traditionally, their
main crops have been oats, buckwheat, and potatoes. Because
of limited land resources, Yi farmers now grow and consume
rice and corn as well. Consumption of meat is limited to
weddings, funerals, and semiannual celebrations. Less salt is
consumed than in other areas of China. Starting in the 1950s,
Yi farmers began to migrate to Xichang City, the capital of the
Liangshan Yi People Autonomous Prefecture, and to the
county seats of counties in the Prefecture. These urban mi-
grants primarily eat rice, meat, and fresh vegetables with little
oats and buckwheat intake.
The protocol for this study was reviewed and approved by
the Chinese Academy of Medical Sciences, Beijing, People’s
Republic of China, and the Committee on Human Research,
Johns Hopkins School of Hygiene and Public Health, Balti-
more. In accord with customary practice in China at the time of
the study, informed consent was not obtained.
Methods
Our study was conducted during March, 1989. A blood
sample was obtained in the morning after a 14-h fast. Serum
was separated in the field and sent to the county hospital
laboratory where it was stoned at -20 #{176}Cuntil it was air-mailed
to the National Center for Clinical Laboratories, Beijing. Se-
rum total cholesterol, high-density-lipoprotein (HDL) choles-
terol, and triglycerides were measured by an enzymatic method
(35, 36) (IL Monarch 2000, Instrumentation Laboratory, Lax-
ington, MA). HDL cholesterol was separated from serum by
precipitation after the addition of phosphotungstic acid and mag-
nesium ion. These analytic procedures were standardized and met
the performance requirements of the Lipoprotein Standardization
Program of the Centers for Disease Control, Atlanta.
Starting on the day that the blood sample was collected,
blood pressure was measured on 3 consecutive days. Before the
blood pressure measurement, participants refrained from stren-
uous activity, smoking, and eating for 30 mm. After a mm-
imum of5 mm ofquiet sitting, blood pressure was measured on
the right arm and recorded to the nearest 2 mm Hg by specially
trained physicians using standard mercury sphygmomanome-
tens. Systolic blood pressure was recorded at the appearance of
the first sound and diastolic pressure at the disappearance of
sounds (Korotkoff phase 5). Three measurements of blood
pressure were obtained each day, and the mean of the nine
blood pressure readings obtained oven the 3-d period of study
was used in the analysis. The observers were trained by using
training tapes from the National Heart, Lung, and Blood Insti-
tute of the National Institutes of Health. After the training
period, the observers were certified by comparing their blood
pressure readings on eight persons (three readings per person)
to those taken by an experienced observer (JH). The differ-
ences in mean readings between observers were all <2 mm Hg
(F test, P>0.95). During the field work, quality control was
maintained by having a supervisor repeat the blood pressure
measurement on a 10% random sample of subjects every day.
If the mean of the three readings differed from those taken by
the first observer by 5 mm Hg for either systolic or diastolic
blood pressure, blood pressure determinations were repeated
for all the subjects measured by that observer on that day. Height
and weight were measured and body mass index [weight (kg)/
height (m2)] was calculated as an index of obesity (37).
Age, race, sex, education level, smoking, medical history
(including antihypertensive medication use), and intakes of
oats and buckwheat were ascertained by local physicians fluent
in both the Yi and Chinese languages. The intake of oats (and
buckwheat) was assessed by asking “How many Jin of oats
(buckwheat) did you eat in the past year?.” A Jin is a Chinese
unit of measure equivalent to 500 g. Information on diet was
also obtained by means of a 24-h dietary recall administered on
3 consecutive days. Agreement between the estimates obtained
by these two methods was moderate, with a correlation coef-
ficient of 0.41 (P < 0.001) for oats and 0.61 (P <0.001) for
buckwheat. This disagreement is primarily due to variability in
intake of these grains. Among the 424 participants who re-
ported eating oats during the preceding year, only 65 (15%)
consumed oats at the time of the 3-d dietar” recall. Likewise,
only 286 (54%) of 531 participants who att buckwheat in the
past year also included it in their diet at this time. The analyses
were based on annual intake of oats and buckwheat, instead of
24-h dietary recall, to reduce the variability in the estimates of
oats and buckwheat intakes. Intakes of total energy, protein,
fat, saturated fatty acids (SFAs), monounsatunated fatty acids
(MUFAs), polyunsaturated fatty acids (PUFAs), cholesterol,
and total fiber were calculated by using the Sichuan Province
section of the Chinese Food Composition Tables (33). In
addition, oats and buckwheat specimens were collected and
their fiber content analyzed at the John Stuart Research Labo-
ratonies, Quaker Oats Company, Barrington, IL. Assessment of
usual physical activity was based on occupational activity
because leisure-time activity was almost nonexistent.
The 857 Yi people in the present study included 515 Yi
farmers and 342 Yi migrants. Seven Yi migrants were excluded
from the analysis because they had been diagnosed as having
hyperlipidemia and took oats for therapy. Distributions of body
weight, blood pressure, and serum lipids were examined, by
intake of grains. Intakes of oats and buckwheat were divided
into four groups: no intake and low, middle, and upper tertiles
of intake. For example, oats intake was categorized as none,
<25 g/d, 25-90 g/d, and >9C g/d. Buckwheat intake was
categorized as none, <40 g/d, 40-200 g/d, and >200 g/d.
Statistical analysis
The differences in cardiovascular disease risk factors and
dietary nutrients among the oats and buckwheat intake groups
were examined by analysis of variance. Univaniate and multi-
variate linear-regression analyses were used to explore the
relation of oats and buckwheat intakes to cardiovascular dis-
ease risk factors. Because any beneficial effects of these grains
on cardiovascular disease risk factors were hypothesized to be
mediated through their soluble fiber content, the relation of risk
factors to fiber intake was also examined. To account for a
possible community effect, additional multivaniate analyses
were performed by adjusting for two urban areas: Xichang City
and the county seats and rural area of residence (Yi farmers).
All analyses were performed by using the SAS statistical anal-
ysis package (38).
by guest on July 14, 2011www.ajcn.orgDownloaded from
368 HE ET AL
Results
The ages of the 850 participants ranged from 15 to 77 y, with
a mean of 34 y. The study participants were lean, with an
average body mass index of 20.8. The mean systolic and
diastolic blood pressures were 107.2 and 66.9 mm Hg, respec-
tively. Only 21 (2.5%) participants had an elevated blood
pressure as defined by a mean systolic or diastolic blood
pressure 140 on 90 mm Hg, respectively, and none of the
study participants were taking antihypertensive medications.
Mean serum total cholesterol (3.86 mmol/L) and triglyceride
(1 .55 mmolfL) values were in the low normal range, by West-
ern standards. Seventy five (8.8%) participants had a total
cholesterol concentration >5.20 mmol/L. The mean HDL-
cholesterol concentration was 1 .43 mmol/L and the ratio of
HDL to total cholesterol was relatively high at 0.39.
Forty-four percent of the sample had consumed oats and
55% had consumed buckwheat during the preceding year. Of
those who had consumed these foods, the mean daily intake
was 70.3 g for oats and 137.7 g for buckwheat.
Distributions of the covariables for oats and buckwheat
consumption are summarized in Tables 1 and 2. Mean age and
dietary intakes of fat, cholesterol, and sodium tended to be
lower in persons who ate oats on buckwheat, whereas their
dietary ratio of polyunsaturated to saturated fatty acids, potas-
sium intake, and alcohol consumption were higher. In addition,
dietary energy intake was significantly greater in those who ate
buckwheat than in those who did not (Table 2).
Average body mass index, blood pressure, and lipid profile
by oats and buckwheat intake are presented in Tables 3 and 4.
At higher oats intake, mean body mass index and blood pnes-
sure were lower, in a dose-response pattern (Table 3). Mean
serum total cholesterol and low-density-lipopnotein cholesterol
were also lower in those who ate oats, although mean concen-
trations were somewhat higher (P > 0.05) in those who ate
>90 g/d compared with their counterparts who ate 26-90 g/d.
Consumption of 25 g oats/d was associated with lower mean
HDL-cholesterol concentrations. The ratio of HDL to total
cholesterol varied little by oats intake.
Average values for body mass index, systolic and diastolic
blood pressure, and HDL cholesterol also varied in a statisti-
cally significant fashion across categories of buckwheat intake,
but did not demonstrate a dose-response relationship (Table 4).
In contrast, mean low-density-lipoprotein (LDL) cholesterol con-
centrations were markedly lower, and the ratio of HDL to total
cholesterol higher, with successively higher buckwheat intakes.
The results of univaniate and multivaniate linear-regression
analyses of oats and buckwheat intakes on cardiovascular dis-
ease risk factors are shown in Table 5. After adjustment for the
covaniables listed in the table, oats intake continued to be
inversely associated with a lower body mass index, as well as
with lower systolic and diastolic blood pressure, serum HDL
cholesterol, ratio of HDL to total cholesterol, and serum tn-
glyceride. Buckwheat intake was associated with lower levels
of serum total and LDL cholesterol, as well as with a higher
ratio of HDL to total cholesterol. In an analysis adjusted for
community of residence, oats intake (100 g/d) was significantly
related to body mass index (/3 =-0.28, P=0.01), systolic
(13=-2.4 mm Hg, P < 0.0001) and diastolic (/3 --1.0 mm
Hg, P=0.04) blood pressure, HDL cholesterol concentration
(13 =-0.12 mmol/L, P < 0.0001), the ratio of HDL to total
cholesterol (/3 =-0.04, P < 0.0001), and triglyceride con-
centration (/3 =-0.09 mmol/L, P=0.05), whereas buckwheat
intake (100 g/d) was associated with total cholesterol concen-
tration (13 =-0.05 mmol/L, P<0.05), the ratio of HDL to
total cholesterol (/3 =0.01, P=0.004), and LDL cholesterol
concentration (/3 =-0.05 mmol/L, P=0.03).
Yi farmers tended to eat more oats and buckwheat than
migrants. For example, 49. 1% of those who did not eat oats
were Yi farmers compared with 91.1% of those who ate >90 g/d.
In separate analyses in the urban and rural groups, however,
similar patterns of associations of grain intake with cardiovascular
disease risk factors were seen in both groups (data not shown).
Because it has been suggested that a threshold effect may
exist for the effect of oats on the lipid profile, persons who
ate 25 g oats/d were compared with those who ate <25 g
oats/d. Findings were similar to the comparisons listed in
Tables 3-5. After adjustment for the covaniables listed in Table
5, systolic blood pressure was 5.3 mm Hg lower, diastolic
blood pressure was 1.8 mm Hg lower, total cholesterol was
0.21 mmol/L lower, HDL cholesterol was 0.20 mmolfL lower,
TABLE 1
Age and intake of dietary nutrients in 850 study subjects by oats intake’
Oats intakes
Group 1, 0 g/d Group 2, <25 g/d Group 3, 25-90 g/d Group 4, >90 g/d
Covariables (n = 426) (n = 176) (n 125) (n = 123) P
Age (y) 35 ±132 34 ± 122 34 ± 142 30 ± i3 0.001
Dietary energy (kJ/d) 13100 ± 4121 13515 ±4577 14481 ±4661 13042 ±5561 0.26
Dietary fat (g/d) 84.4 ± 51.425 85.8 ± 58.525 61.8 ± 5492 41.9 ± 40.2’ 0.001
P:S 1.37 ±1.1625 1.29 ±1.1125 2.14 ±1.12 2.08 ±1.04 0.001
Dietary cholesterol (mg/d) 214 ± 310 186 ± 21725 86 ± 204’ 38 ± 83’ 0.001
Dietary sodium (mgjd) 3539 ± 312725 3851 ± 341425 2304 ± 1974 2738 ± 181  0.001
Dietary potassium (mg/d) 4387 ± 293625 4518 ± 292925 7410 ± 38212 6651 ± 3616 0.001
Alcohol intake (g/d) 25.6 ± 40.124 35.6 ± 52.3 30.5 ± 51.5 41.0 ± 59.9’ 0.003
I ± SD. P:S, polyunsaturated to saturated fatty acid ratio.
2Significantly different from group 4, P<0.05.
3Significantly different from group 1, P<0.05.
4Significantly different from group 2, P<0.05.
5Significantly different from group 3, P<0.05.
by guest on July 14, 2011www.ajcn.orgDownloaded from
OATS AND CARDIOVASCULAR DISEASE 369
TABLE 2
Age and intake of dietary nutrients in 850 study subjects by buckwheat intake’
Buckwheat intakes
Group 1, 0 g1/d Group 2, <40 g/d Group 3, 40-200 g/d Group 4, >200 g/d
Covariables (n = 319) (i = 207) (n = 161) (n = 163) P
Age (y) 36 ±1323 34 ± 13’ 32 ± 13 30 ± l2 0.0()1
Dietary energy (kJ/d) 12531 ± 41 13235 13498 ± 4448 14017 ± 5059 14485 ± 4762 0.001
Dietary fat (g/d) 82.8 ± 58.723 91.7 ± 55523 60.4 ±44#{149}74.5 539 ± 41.9 0.001
P:S 1.44 ±1.17235 1.07 ± 1.0O” 1.86 ±1.15 2.17 ±1.06245 0.001
Dietary cholesterol (mg/d) 205 ± 27723 248 ± 33123 84 ± 145 49 ± I l6 0.001
Dietary sodium (mg/d) 3491 ± 3234235 4185 ± 32282 2919 ± 2224’’ 2231 ± 2030245 0.001
Dietary potassium (mg/d) 4020 ± 275923 4084 ± 276623 6547 ± 3288’ 7569 ± 3627245 0.()01
Alcohol intakes (g/d) 20.9 ± 33.2235 31.9 ± 46.824 41.9 ± 4J.545 39.3 ± 57.2 0.0()1
.t ± SD. P:S, polyunsaturated to saturated fatty acid ratio.
2Significantly different from group 3, P<0.05.
3Significantly different from group 4, P<0.05.
4Significantly different from group 1, P<0.05.
5Significantly different from group 2, P<0.05.
TABLE 3
Cardiovascular disease risk factors in 850 study subjects by oats intake’
Oats intakes
Group 1, 0 g/d Group 2, <25 g/d Group 3, 25-90 g/d Group 4, >90 g/d
Variables (n = 426) (n 176) (n 125) (n = 123) P
Body mass index 20.9 ± 2.323 20.9 ± 2.323 20.5 ±  20.1 ± 0.001
Systolic BP (mm Hg) 109.7 ± 12.42 108.5 ± 13.023 103.9 ± 10.6’s 100.4 ±9924.5 0.001
Diastolic BP (mm Hg) 68.3 ± 10.323 67.2 ± 10.1’ 65.9 ±  62.6 ± 8.9243 0.001
Serum total cholesterol (mmol/L) 4.03 ±0.9923 399 ± 1.0423 3.45 ± 0.91’ 3.59 ± 0.86’ 0.001
HDL cholesterol (mmol/L) 1.49 ± 0.452 1.48 ± 0.4423 1.34 ± 0.4O’ 1.23 ± 0.28245 0.001
LDL cholesterol (mmol/L) 1.85 ±0.942 1.78 ± 0.862 1.54 ± 0.85 1.76 ± 0.84 0.01
HDL:total cholesterol 0.39 ± 0.14 0.39 ± 0.14 0.40 ± 0.14 0.36 ± 0.12 0.1
Serum triglyceride (mmol/L) 1.59 ±0.97 1.67 ± l.01 1.49 ± 0.86 1.32 ± 0.61 0.007
I ± SD. BP, blood pressure. Body mass index in kg/m2.
2Significantly different from group 3, P<0.05.
3Significantly different from group 4, P<0.05.
4Significantly different from group 1, P<0.05.
SSignificantly different from group 2, P<0.05.
and the ratio of HDL to total cholesterol was 0.03 lower (all P <
0.01) in subjects who had eaten 25 g oats/d compared to those
who had not. Likewise, the adjusted differences between those
who had eaten 44J g buckwheat/d and had not or eaten buck-
wheat <40 g/d were -2.6 mm Hg for systolic blood pressure,
-0.22 mmol/L for total cholesterol, -0.24 mmol/L for LDL
cholesterol, and 0.03 for the ratio of HDL to total cholesterol (all
P<0.01).
Laboratory analysis demonstrated that each 100 g oats con-
tamed 10.2 g total fiber, 3.9 g soluble fiber, 13.9 g protein, and
9.9 g fat. For each 100 g buckwheat, there were 26.0 g total
fiber, I .7 g soluble fiber, 9.2 g protein, and 1 .9 g fat. The
results of the univaniate and multivariate linear-regression anal-
yses of total and soluble fibers from oats and buckwheat on
cardiovascular disease risk factors are shown in Table 6. After
adjustment for the covariables listed in the table, water-soluble
fiber was negatively and significantly related to systolic blood
pressure, serum total cholesterol, and HDL cholesterol,
whereas total fiber was related negatively to serum total and
LDL cholesterol. In the multivaniate model adjusted for com-
munity of residence, water-soluble fiber was negatively and
significantly associated with systolic blood pressure, total cho-
lesterol, and HDL cholesterol, but total fiber was not associated
with blood pressure or lipids.
Discussion
Because the population in the present study consumed fairly
high amounts of oats and buckwheat from an early age, the
results seen here probably represent the long-term effect of
these grains on cardiovascular disease risk factors. Special
strengths ofthe present study include its relatively large sample
size as well as the availability of detailed information on
dietary consumption and cardiovascular disease risk factors. In
addition, the fact that the results were from a random sample of
free-living men enhances the generalizability of the findings.
The present study identified a significantly lower mean sys-
tolic and diastolic blood pressure with progressively higher
intakes of oats. This association followed a dose-response
pattern and was independent of age, body mass index, alcohol
use, as well as dietary intakes of energy, cholesterol, sodium,
by guest on July 14, 2011www.ajcn.orgDownloaded from
370 HE ET AL
TABLE 4
Cardiovascular disease risk factors in 850 study subjects by buckwheat intake’
Buckwheat intakes
Group 1, 0 g/d Group 2, <40 g/d Group 3, 40-200 g/d Group 4, >200 g/d
Variables (n 319) (n 207) (n = 161) (n = 163) P
Body mass index 20.7 ± 2.22 21.3 ±  20.4 ± 2.12 20.5 ± 1.92 0.001
Systolic BP (mm Hg) 107.6 ± 12.3245 111.4 ± 14.1 104.7 ± 10.723 103.4 ± 9.623 0.001
Diastolic BP (mm Hg) 67.6 ±  68.3 ± i0.95 65.8 ± 10.723 64.6 ± 8.523 0.001
Serum total cholesterol (mmol/L) 4.03 ± 1.03 4.10 ± i.O75 3.71 ± 0.85235 3.38 ± 0.782 0.001
HDL cholesterol (mmol/L) 1.37 ± 0442.4 1.52 ± O.44 1.48 ± 0.43’ 1.38 ± 0.3624 0.001
LDL cholesterol (mmollL) 1.99 ± #{216}9545 1.86 ± 0.91 1.57 ± 0.8323 1.43 ± 0.7223 0.001
HDL:total cholesterol 0.35 ± 0.13245 0.39 ± 0.14 0.41 ± 0.14 0.43 ± 0.1523 0.001
Serum triglyceride (mmol/L) 1.50 ± 0.86 1.65 ± 1.06 1.63 ± 0.97 1.47 ± 0.78 0.1
g ± SD. BP, blood pressure. Body mass index in kg/m2.
2Significantly different from group 2, P<0.05.
3Significantly different from group 1, P<0.05.
4Significantly different from group 3, P<0.05.
5Significantly different from group 4, P<0.05.
TABLES
Unadjusted and adjusted differences (linear-regression analysis) in cardiovascular disease risk factors for 100-g/d intakes of oats and buckwheat’
Oats intakes Buckwhe at intakes
Unadjusted Adjusted Unadjusted Adjusted
Variables /3 SE /3 SE f3 SE j3 SE
Body mass index -0.47 0.112 -0.25 0.ii3 -0.09 0.06 0.04 0.06
Systolic BP (mm Hg) -4.3 0.62 -3.1 0.62 -1.2 0.32 -0.3 0.3
Diastolic BP (mm Hg) -2.5 #{149}52 -1.3 54 -0.7 0.2 0.1 0.2
Serum total cholesterol (mmol/L) -0.19 #{216}#{216}52 #{216}4 0.04 -0.17 0.022 -0.07 0.02
HDL cholesterol (mmol/L) -0.13 0.022 -0.13 0.022 -0.01 0.01 -0.00 0.01
LDL cholesterol (mmolIL) -0.03 0.05 0.07 0.05 -0.14 0.022 -0.06 0.02
HDL:total cholesterol -0.01 0.01 -0.03 0.012 0.02 0.00 0.01 0.00
Serum triglyceride (mmolfL) -0.14 #{216}#{149}#{216}54 -0.10 0.O4 -0.01 0.02 0.02 0.02
All analyses adjusted for age and dietary intakes of energy, cholesterol, and alcohol. In addition, body mass index (in kg/m2) was adjusted for dietary
fat and physical activity, blood pressure was adjusted for body mass index and dietary intake of sodium and potassium, and serum lipids were adjusted for
body mass intake, dietary intake of fat, and the ratio of polyunsaturated to saturated fatty acids. BP, blood pressure.
2-4 Statistically significant: 2p<0.001,  p <0.05,  p <0.01.
and potassium. Dietary buckwheat was associated with lower
blood pressure in univanate analysis, but this was not the case
after adjustment for other covaniables. Further analysis mdi-
cated that water-soluble fiber, but not total fiber, was indepen-
dently related to blood pressure. Previous studies of the asso-
ciation between dietary fiber and blood pressure have yielded
inconsistent results (39-41). In clinical trials, oats supplemen-
tation did not alter blood pressure (22, 23, 31). In all of these
trials, however, blood pressure was not the primary outcome
variable and hypertensive patients were excluded (22, 23, 31).
Apossible mechanism by which oats intake might lower blood
pressure is through alterations in insulin metabolism. Higher
insulin concentrations and insulin resistance have been linked to
higher blood pressures and hypertension (42, 43). In healthy
persons, consumption of oat bran has been demonstrated to lower
plasma insulin concentrations and to ameliorate insulin resistance
(44, 45).
Higher buckwheat intake was associated with lower total and
LDL serum cholesterol, with no effect on HDL cholesterol.
Thus, the ratio of HDL to total cholesterol was higher at higher
buckwheat intakes, independent of other variables. The asso-
ciation of oats intake with serum lipids seen in univariate
results in the present study is consistent with the results of most
clinical trials. Ripsin (46) pooled the results of 12 randomized,
controlled trials, which had evaluated the lipid-lowering effects
of oats in free-living subjects. The overall effect of oats intake
was to lower serum total cholesterol by 0.15 mmollL (95% CI:
-0.22 to -0.09), with a more pronounced effect in persons
with a higher intake of oats and a higher initial total serum
cholesterol concentration. In the present study, after adjustment
for the other covariables, oats intake was not significantly associ-
ated with either serum total or LDL-cholesterol concentrations,
but was associated with lower concentrations of HDL cholesterol
and triglyceride.
Whether dietary oats lower serum cholesterol concentrations
by substitution of carbohydrates fon saturated fats or by a direct
effect of the dietary fiber contained in oats remains an unan-
swered question. Swain et al (3 1) compared the effects of oats
and low-fiber wheat diets on serum lipids. Both types of
supplements lowered serum total cholesterol concentrations by
an average of 7-8% compared with baseline. However, a
decrease in LDL cholesterol in the oats group was accompa-
nied by a rise in HDL cholesterol. The low-fiber diet, on the
other hand, lowered HDL-cholestenol concentrations. The pan-
ticipants ate less saturated fat and cholesterol and more poly-
unsaturated fat during both periods of supplementation than at
by guest on July 14, 2011www.ajcn.orgDownloaded from
OATS AND CARDIOVASCULAR DISEASE 371
TABLE 6
Unadjusted and adjusted differences (linear-regression analysis) in cardiovascular disease risk factors for 10-g/d intakes of water-soluble or total fiber
from oats and buckwheat’
Water-sol uble fiber Total fiber
Unadjusted Adjusted Unadjusted Adjusted
Variables f3 SE /3 SE 3 SE 3 SE
Body mass index -0.59 0.172 -0.19 0.18 -0.04 0.02’ 0.00 0.02
Systolic BP (mm Hg) -6.0 0.92 -3.7 1.0 -0.5 0.12 -0.21 0.11
Diastolic BP (mm Hg) -3.5 0.82 1.2 0.7 -0.3 0.i 0.02 0.08
Serum total cholesterol (mmollL) -0.46 0.072 -0.16 0.07 -0.06 0.012 -0.02 0.01
HDL cholesterol (mmolfL) -0.13 0.032 -0.12 0.042 -0.01 0.00 -0.00 0.00
LDL cholesterol (mmolfL) -0.26 0.072 -0.01 0.07 -0.04 0.012 -0.02 0.0i3
HDL:total cholesterol 0.02 0.01 -0.01 0.01 0.005 0.0012 0.002 0.001
Serum triglyceride (mmol/L) -0.14 0.07 -0.07 0.07 -0.01 0.01 0.00 0.01
IAll analyses adjusted for age and dietary intake of energy, cholesterol, and alcohol. In addition, body mass index (in kg/rn2) was adjusted for dietary
fat and physical activity, blood pressure was adjusted for body mass index and dietary intake of sodium and potassium, and serum lipids were adjusted for
body mass intake, dietary intake of fat, and the ratio of polyunsaturated to saturated fatty acids. BP, blood pressure.
2-4 Statistically significant: 2p<0.001, ?p < 0.05, p<0.01.
baseline (31). Most (80%) of the study participants were
women and their average serum cholesterol concentration was
in the desirable range, 4.81 mmollL. Studies in hypercholes-
terolemic men, on the other hand, have shown a greater reduc-
tion in serum lipids with oats than with wheat, rice, on corn
supplementation (21-24). Recent studies suggest that -glucan,
a water-soluble fiber, is the hypocholesterolemic component in
oats (26, 47, 48). In our study, both total and water-soluble
fiber from oats and buckwheat were significantly and indepen-
dently associated with lower serum total cholesterol, even
though the average serum cholesterol in the study population
was low. Soluble fiber may lower serum cholesterol concen-
trations through several mechanisms. It has been suggested that
soluble fiber binds strongly to bile acids and increases fecal
bile acid excretion (27, 49, 50). The loss of bile acids creates a
demand for cholesterol to facilitate the synthesis of bile acids
and diverts the available cholesterol from lipoprotein synthesis.
It also decreases the availability of bile acids for optimal fat
digestion and absorption (27, 47, 48, 51). In addition, fiber delays
gastric emptying, slowing access of nutrients to digestive enzymes
and to absorptive surfaces of the small intestine (52). Colonic
bacteria also ferment soluble fiber to form short-chain fatty acids,
which decrease hepatic cholesterol synthesis (53). In addition to
fiber, short-chain fatty acids present in oats also may play a role in
lowering serum lipids (54).
In the present study, oats intake was associated with a lower
mean HDL-cholesterol concentration. Most clinical trials, in
contrast, have shown that oats intake selectively lowers serum
LDL cholesterol without affecting HDL cholesterol (18, 19,
21-26, 28). Only one study identified a decrease in HDL
cholesterol with oat bran supplementation (20). The results
may differ in the present study because of the low average
concentrations of LDL cholesterol in the study population.
Even though a higher oats intake was associated with a lower
ratio of HDL to total cholesterol in multiple analysis, the
absolute ratio was very high. Thus, the HDL cholesterol low-
ening effect of oats intake was associated with minimal, if any,
additional cardiovascular disease risk. Because higher concen-
tnations of HDL cholesterol protect against coronary heart
disease (47, 48), the long-term effect of oats intake on HDL
cholesterol deserves more study.
Our study suggests that intake of grains rich in water-soluble
fiber in the presence of reasonable amounts of total fiber, like
oats and buckwheat, are associated with lower serum choles-
terol and blood pressure values. These results imply that a
high-fiber diet may be a useful part of a lifestyle modification
to prevent cardiovascular diseases. The effect of dietary oats on
blood pressure and the association of buckwheat intake with
cardiovascular disease risk factors should be investigated fun-
ther in clinical trials. U
We express our appreciation to the Department of Public Health and
Anti-epidemic Stations of Liangshan Yi People Autonomous Prefecture,
Butuo, Meigu, and Zhaojue counties, the People’s Republic of China, for
their help in performing field work, and the National Center for Clinical
Laboratories, People’s Republic of China, for their help in performing
laboratory work.
References
1.National Center for Health Statistics and the American Heart Associ-
ation. Facts about cardiovascular disease. Circulation 1992;85:A103
(abstr).
2. World Health Organization. 1990 World health statistics annual. Ge-
neva: World Health Organization, 1991.
3. Stokes J III, Kannel WB, Wolf PA. Blood pressure as a risk factor for
cardiovascular disease. The Framingham study-30 years of follow-
up. Hypertension 1989;12(suppl 1):I-13-8.
4. MacMahon 5, Peto R, Cutler J, et al. Blood pressure, stroke, and
coronary heart disease, part 1: prolonged differences in blood pressure:
prospective observational studies corrected for the regression dilution
bias. Lancet 1990;335:765-74.
5. Stamler J, Stamler R, Neaton JD. BlOOd pressure, systolic and dia-
stolic, and cardiovascular risks: U.S. population data. Arch Intern Med
1993;153:598-615.
6. Castelli WP, Anderson K, Wilson PWF, Levy D. Lipids and risk of
coronary heart disease. The Framingham Study. Ann Epidemiol 1992;
2:23-8.
7. Reed D, Benfante R. Lipid and lipoprotein predictors of coronary heart
disease in elderly men in the Honolulu Heart program. Ann Epidemiol
1992;2:29-34.
8. KIag Mi, Ford DE, Mead LA, He J, Whelton PK, Levine DM. Serum
cholesterol in youth and subsequent cardiovascular disease. NEngI J
Med 1993;328:313-8.
9. SHEP Cooperative Research Group. Prevention of stroke by antihy-
by guest on July 14, 2011www.ajcn.orgDownloaded from
372 HE ET AL
pertensive drug treatment in older persons with isolated systolic hy-
pertension. Final results of the systolic hypertension in the elderly
program. JAMA 1991;265:3244-64.
10. Hypertension Detection and Follow-up Program Cooperative Group.
Persistence of reduction in blood pressure and mortality of participants
in the Hypertension Detection and Follow-up Program. JAMA 1988;
259:2113-22.
11.Collins R, Peto R, MacMahon 5, et al. Blood pressure, stroke, and
coronary heart disease, II: short-term reductions in blood pressure:
overview of randomized drug trials in their epidemiological context.
Lancet 1990;335:827-38.
12. Hebert P, Moser M, Mayer J, Glynn Ri, Hennekens CH. Recent
evidence on drug therapy of mild to moderate hypertension and de-
creased risk of coronary heart disease. Arch Intern Med 1993;153:
578-81.
13. Lipid Research Clinics Program. The Lipid Research Clinics Coronary
Primary Prevention Trial results, I: reduction in incidence of coronary
heart disease. JAMA 1984;251:351-64.
14. Fnick MH, Elo 0, Haapa K, et al. Helsinki Heart Study: primary-
prevention trial with gemfibrozil in middle-aged men with dyslipi-
demia: safety of treatment, change in risk factors, and increased
incidence ofcoronary heart disease. N EngI J Med 1987;317:1237-45.
15. Whelton PK, Adams-Campbell LL, Appel Li, et al. National High
Blood Pressure Education Program Working Group report on primary
prevention of hypertension. Arch Intern Med 1993;153:186-208.
16. Joint National Committee on Detection, Evaluation, and Treatment of
High Blood Pressure. The fifth report of the Joint National Committee
on the Detection, Evaluation, and Treatment of High Blood Pressure
(JNC V). Arch Intern Med 1993;153:154-83.
17. Dc Groot AP, Luyken R, Pikaar NA. Cholesterol-lowering effect of
rolled oats. Lancet 1963;2:303-4.
18. Kirby RW. Oat-bran intake selectively lowers serum low-density
lipoprotein cholesterol concentrations of hypercholesterolemic men.
Am J Clin Nutr 1981;34:824-9.
19. Anderson JW, Story L, Siding B, Chen W-JL, Petro MS. Story J.
Hypocholesterolemic effects of oat-bran or bean intake for hypercho-
lesterolemic men. Am J Clin Nutr 1984;40:1 146-55.
20. Demark-Wahnefried W, Bowering J, Cohen PS. Reduced serum cho-
lesterol with dietary change using fat-modified and oat bran supple-
mented diets. J Am Diet Assoc 1990;90:223-9.
21 .Anderson JW, Spencer DB, Hamilton CC, et al. Oat-bran cereal lowers
serum total and LDL cholesterol in hypercholesterolemic men. Am J
Clin Nutr 1990;52:495-9.
22. Kestin M, Moss R, Clifton PM, Nestel PJ. Comparative effects of three
cereal brans on plasma lipids, blood pressure, and glucose metabolism
in mildly hypercholesterolemic men. Am J Clin Nutr 1990;52:661-6.
23. Horn LV, Moag-Stahlberg A, Liu K, et al. Effects on serum lipids of
adding instant oats to usual American diets. Am J Public Health
1991;81: 183-8.
24. Anderson JW, Gilinsky NH, Deakins DA, et al. Lipid response of
hypercholesterolemic men to oat-bran and wheat bran intake. Am J
Clin Nutr 1991;54:678-83.
25. Spiller GA, Farquhar JW, Gates TE, Nichols SF. Guar gum and plasma
cholesterol. Effect of guar gum and oat fiber source on plasma lipopro-
tein and cholesterol in hypercholesterolemic adults. Arteniosclen
Thromb 1991;11:1204-8.
26. Davidson MH, Dugan LD, Burns JM, Bova J, Story K, Drennan KB.
The hypocholesterolemic effects of j3-glucan in oatmeal and oat bran.
A dose-controlled study. JAMA 1991;265:1833-9.
27. Judd PA, Truswell AS. The effect of rolled oats on blood lipids and
fecal steroid excretion in man. Am J Clin Nutr 1981;34:2061-7.
28. Horn LW, Liu K, Parker D, et al. Serum lipid response to oat product
intake with a fat-modified diet. J Am Diet Assoc 1986;86:759-64.
29. Horn LW, Emidy LA, Liu K, et al. Serum lipid response to a fat-
modified, oatmeal-enhanced diet. Prey Med 1988;17:377-86.
30. Gold K, Wong N, Tong A, et al. Serum apolipoprotein and lipid profile
effects of an oat-bran-supplemented, low-fat diet in children with
elevated serum cholesterol. Ann NY Acad Sci 1991;623:429-31.
31. Swain iF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects
of oat bran and low-fiber wheat on serum lipoprotein levels and blood
pressure. N Engl J Med 1990;322: 147-52.
32. Birkeland 1G. Gullestad L, Falch D, Torsvik H. Oat bran and serum
cholesterol. N EngI J Med 1990;332: 1748-9 (letter).
33. Institute of Nutrition of Chinese Academy of Medical Sciences. Chi-
nese Food Composition Tables. 3rd ed. Beijing: People’s Health Press,
1985.
34. He J, Klag Mi, Whelton PK, et al. Migration, blood pressure pattern,
and hypertension: the Yi Migrant Study. Am J Epidemiol 1991;134:
1085-101.
35. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic
determination of total serum cholesterol. Clin Chem 1974;20:470-5.
36. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-
coupled method for the calorimetric determination of serum triglycer-
ides. Clin Chem 1983;29:538-42.
37. Keys A, Fidanza F, Karvonen Mi, Kumura N, Taylor HL. Indices of
relative weight and obesity. J Chron Dis 1972;25:329-43.
38. SAS Institute Inc. SAS/STAT user’s guide, release 6.03. Cary, NC:
SAS Institute mc, 1990.
39. Margetts BM, Beilin U, Vandongen R, Armstrong BK. A randomized
controlled trial of the effect of dietary fiber on blood pressure. Clin Sci
1987;72:343-50.
40. Schlamowitz P, Halberg T, Warnoe 0, Ryttig K. Treatment of mild to
moderate hypertension with dietary fiber. Lancet 1987;2:622-3.
41. Rossner 5, Anderson I-L, Ryttig K. Effects of a dietary fiber supple-
ment to a weight reduction programme on blood pressure. A random-
ized, double-blind, placebo-controlled study. Acta Med Scand 1988;
223:353-7.
42. Ferrannini E, Shieh SM, Fuh MT. et al. Insulin resistance in essential
hypertension. N Engl J Med 1987;317:350-7.
43. Ferrannini E, Haffner SM, Stern MO. Essential hypertension: an
insulin-resistance state. J Cardiovasc Parmacol 1990;15(suppl 5):s18-
25.
44. Braaten IT, Wood PJ, Scott FW, Riedel KD, Poste LM, Collins MW.
Oat gum lowers glucan and insulin after an oral glucose load. Am J
Clin Nutr 1991;53:1425-30.
45. Wood PJ. Physicochemical properties and physiological effects of the
(1-*3) (1-’4)--D-Glucan from oats. In: Furda I, Brine Ci, eds. New
developments in dietary fiber. New York: Plenum Press, 1990.
46. Ripsin CM. Oat products and lipid-lowering: a meta-analysis. Circu-
lation 1992;85:864(abstr).
47. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High
density lipoprotein as a protective factor against coronary heart dis-
ease. The Framingham Study. Am J Med 1977;62:707-14.
48. Shinnick FL, Ink SL, Marlett JA. Dose-response to a dietary oat bran
fraction in the cholesterol-fed rat. J Nutr 1990;120:561-86.
49. Story JA, Kritchevsky D. Comparison of the binding of various bile
acids and bile salts in vitro by several types of dietary fiber. J Nutr
1976;106:1292-4.
50. Vahouny GV, Tombes R, Cassidy MM, Knitchevsky D, Gallo LL.
Dietary fiber V: Binding of bile salts, phospholipids and cholesterol
from mixed micelles by bile acid sequestrants and dietary fibers.
Lipids 1980;15:1012-8.
51. Story JA. Dietary fiber and lipid metabolism. Proc Soc Exp Biol Med
1985;180:447-52.
52. Anderson JW. Hypocholesterolemic effects of oat products. In: Furda
I, Brine CI, eds. New developments in dietary fiber. New York:
Plenum Press, 1990.
53. Nyman MG-L, Asp N-GL. Fermentation of oat fiber in the rat intes-
tinal tract: a study of different cellular areas. Am J Clin Nutr 1988;
48:274-8.
54. Anderson JW, Gustafson NJ. Hypocholesterolemic effects of oats and
bean products. Am J Clin Nutr 1988;48:749-53.
by guest on July 14, 2011www.ajcn.orgDownloaded from
... Although animal models are vital in understanding physiological mechanisms and elucidating the potential health relevance, human intervention studies are scarce and inconsistent in supporting BW benefits identified in nonhuman studies. In the literature, a cross-sectional study with a questionnaire-based assessment of oat and buckwheat intakes showed a significant reduction in both systolic (−3.1 mm Hg, p < 0.001) and diastolic (−1.3 mm Hg, p < 0.01) BP [34]. Due to the study design (i.e., cross-sectional), this survey was not included in our analysis. ...
... Hence, a possibility exists that there is an effect of BW on these parameters, since BW has higher levels of soluble than insoluble fiber. Only two cross-sectional studies [34,35] have suggested that consumption of BW seeds may be a preventative factor for hypertension, dyslipidemia and hyperglycemia. However, the inherent limitations of a cross-sectional design render these findings indicative. ...
Article
Full-text available
Buckwheat (BW) is suggested to have beneficial effects, but evidence on how it affects cardiometabolic health (CMH) is not yet established. We aimed to assess the effects of BW and/or its related bioactive compounds on cardiovascular disease (CVD) risk markers in adults. Five databases were searched for eligible studies. Observational prospective studies, nonrandomized or randomized trials were considered if they assessed BW, rutin or quercetin-3-glucoside intake and CVD risk markers. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for reporting. We selected 16 human studies based on 831 subjects with mild metabolic disturbances, such as hypercholesterolemia, diabetes and/or overweight. Eight studies, investigating primarily grain components, were included in the meta-analyses (n = 464). High study heterogeneity was present across most of our analyses. Weighted mean difference (WMD) for subjects receiving BW supplementation, compared to controls, were − 0.14 mmol/L (95% CI: −0.30; 0.02) for total cholesterol (TC), −0.03 mmol/L (95% CI: −0.22; 0.16) for LDL cholesterol, −0.14 kg (95% CI: −1.50; 1.22) for body weight, −0.04 mmol/L (95% CI: − 0.09;0.02) for HDL cholesterol, −0.02 mmol/L (95% CI: −0.15; 0.11) for triglycerides and −0.18 mmol/L (95% CI: −0.36; 0.003) for glucose. Most of the studies (66.7%) had concerns of risk of bias. Studies investigating other CVD markers were scarce and with inconsistent findings, where available. Evidence on how BW affects CMH is limited. However, the available literature indicates that BW supplementation in mild dyslipidaemia and type 2 diabetes may provide some benefit in lowering TC and glucose, albeit non-significant. Our work highlights the need for more rigorous trials, with better methodological rigor to clarify remaining uncertainties on potential effects of BW on CMH and its utility in clinical nutrition practice.
... (3) Tartary buckwheat reduced the level of low-density lipoprotein cholesterol, total cholesterol, triacylglycerols, glutamic-pyruvic transaminase, glutamic oxaloacetic transaminase, creatinine, urea, uric acid, and malonaldehyde, but increased the level of total protein and the activity of glutathione peroxidase in experimental rats, mice, and piglets [35][36][37]. (4) By epidemiological and clinical studies, the impact of Tartary buckwheat on the prevention of tiredness and cardio-vascular diseases was confirmed [38][39][40][41]. According to the epidemiological study performed in Liangshan, Sichuan, China, Tartary buckwheat nutrition correlated with a lower concentration of low-density-lipoprotein cholesterol, lower total cholesterol, and a higher ratio of serum high-density-lipoprotein in cholesterol in people regularly consuming Tartary buckwheat [41]. ...
... (4) By epidemiological and clinical studies, the impact of Tartary buckwheat on the prevention of tiredness and cardio-vascular diseases was confirmed [38][39][40][41]. According to the epidemiological study performed in Liangshan, Sichuan, China, Tartary buckwheat nutrition correlated with a lower concentration of low-density-lipoprotein cholesterol, lower total cholesterol, and a higher ratio of serum high-density-lipoprotein in cholesterol in people regularly consuming Tartary buckwheat [41]. ...
Article
Full-text available
In Tartary buckwheat (Fagopyrum tataricum), the edible parts are mainly grain and sprouts. Tartary buckwheat contains protecting substances, which make it possible for plants to survive on high altitudes and under strong natural ultraviolet radiation. The diversity and high content of phenolic substances are important for Tartary buckwheat to grow and reproduce under unfriendly environmental effects, diseases, and grazing. These substances are mainly flavonoids (rutin, quercetin, quercitrin, vitexin, catechin, epicatechin and epicatechin gallate), phenolic acids, fagopyrins, and emodin. Synthesis of protecting substances depends on genetic layout and on the environmental conditions, mainly UV radiation and temperature. Flavonoids and their glycosides are among Tartary buckwheat plants bioactive metabolites. Flavonoids are compounds of special interest due to their antioxidant properties and potential in preventing tiredness, diabetes mellitus, oxidative stress, and neurodegenerative disorders such as Parkinson’s disease. During the processing and production of food items, Tartary buckwheat metabolites are subjected to molecular transformations. The main Tartary buckwheat traditional food products are bread, groats, and sprouts.
... There is also evidence that modern wheat breeding practices may contribute to higher exposure to disease inducing gluten proteins (van den Broeck et al., 2010) and there is increasing evidence for non-coeliac gluten sensitivity associated with Irritable Bowel Syndrome (IBS) and other disorders (Catassi et al., 2013). There is also considerable interest in buckwheat for the production of nutraceutical preparations (He et al., 1995) and it is considered to have potential for "functional food" development as it can provide health benefits beyond basic nutrition (Li and Zhang 2001;Bonafaccia et al., 2003a, b). Buckwheat has a high protein content with the plant proteins having high cholesterol-lowering properties (Huff and Carroll, 1980). ...
... Buckwheat has a high protein content with the plant proteins having high cholesterol-lowering properties (Huff and Carroll, 1980). The inclusion of 30 g buckwheat in the daily diet has been shown to produce clinically relevant reductions in serum total and LDL-cholesterol, triglycerides and increases in HDL-cholesterol, thus reducing the risk of cardiovascular diseases (He et al., 1995). Buckwheat bran and hulls have 2-7 times higher antioxidant activity than barley, triticale and oats (Holasova et al., 2002) and the bran is a rich source of dietary fibre. ...
Article
The pseudocereal buckwheat (Fagopyrum species) has a wide range of agronomic and health benefits that make it a promising crop for sustainable agricultural production. Buckwheat is gluten free and has been shown to provide health benefits beyond basic nutrition. This study examined the effect of sowing date on growth, development, yield and nutritional quality of the varieties Bamby and Čebelica over 3 growing seasons (2016−18) in north-east England. The low grain yield of 0.77 t ha−1 (average across varieties, sowing date and season) was associated with a prolonged growing season (150–190 days) in the cool temperate climate of north-east England. The highest grain yield of 1.42 t ha−1 was achieved from the variety Bamby in 2017 although there was no significant effect of variety or sowing date on grain yield. The average quadrat grain yield of 1.63 t ha-1 (based on quadrat sampling) was much higher than the average combine yield and likely reflects significant seed losses at harvest attributable to the very small seed and asynchronous crop ripening/maturity. The average protein 15.2 %, Fe of 104.5–138.7 mg kg−1 and Zn (average of 31.3 mg kg−1) concentrations are generally higher than those reported for the major cereals. Late sowing resulted in a large 7.5-fold decline in total antioxidants with the highest concentration (5165.5 μg g-1) found in the variety Bamby sown in mid-April. Buckwheat has clear potential for production in the organic and low-input sectors in northern England if the significant seed losses at harvest can be avoided as there is increased market demand for gluten-free products helping promote human health.
... Whole buckwheat groats (the hulled seeds) have been reported to contain 550 mg/g starch, 120 mg/g protein, 70 mg/g total dietary fibre (TDF), 40 mg/g lipid, 20 mg/g soluble carbohydrates (Bonafaccia et al. 2003). The inclusion of 30 g buckwheat in the daily diet has been found sufficient to produce clinically relevant reductions in serum total and LDL-cholesterol, triglycerides and increases in HDL-cholesterol, thus reducing the risk of cardiovascular diseases (CVD) (He et al. 1995).Breads containing buckwheat flour have been attempted by and advocated for their low glycemic index and higher antioxidants content (Lin et al. 2009). ...
Article
Full-text available
Pea processing industry generates pods as waste accounting for 30–40% of by-product mass. The present study focuses on the utilization of pea pod powder (PPP) as source of fibre in buckwheat enriched bread (20%). The composite dough was evaluated for textural attributes, stickiness and extensibility. Addition of PPP caused a decrease in stickiness, work of adhesion, extensibility and resistance to extension. The inherent blend of soluble and insoluble fibres in PPP was found to exert a synergistic and counterbalancing act in improving crumb texture. PPP decreased the specific volume of breads, but enhanced the crumb moisture content. Followed by BW bread, 15% PPP bread was rated best in terms of appearance and overall acceptability. Overall, inclusion of PPP in the bread making process led to desirable modification of textural properties during storage of bread. These breads were found have better shelf life besides high fibre (12.1%) and functional compounds.
... Several clinical studies have also shown potential health benefits of BW. He et al. (1995) has shown that daily intake of 100 g of lowered both total and LDL cholesterol in 850 people of ethnic minority in china. In a doube blind crossover study from Wieslander et al. (2011) samples were supplemented with normal BW (16.5 mg rutin/day) and tartary BW cookies (359.7 mg rutin/day) for two weeks. ...
Article
Full-text available
Functional foods play an important role in maintaining a healthy lifestyle and reducing the risk factors of various diseases. Most foods have a functional element which is responsible for improving the healthy state. All food substances such as fruits, vegetables, cereals, meat, fish, dairy contain functional ingredients. A wide range of naturally occurring substances from plant and animal sources having active components which play a role in physiological actions deserve attention for their optimal use in maintaining health. The market for functional food is keep on expanding, and the global market is projected to reach a value of at least 91 billion USD soon. Overwhelming evidence from preclinical (in vitro and in vivo) and clinical studies have shown that intake of functional foods could have an impact on the prevention of chronic diseases, especially cancer, cardiovascular diseases, gastrointestinal tract disorders and neurological diseases. Extensive research needs to be done to determine the potential health benefits for the proper application of these foods to improve health state and combat chronic disease progression. The aim of this review is to conduct a thorough literature survey, to understand the various classification of functional foods and their health benefits.
... Consumption of pseudocereals such as buckwheat and buckwheat incorporated products can decrease total cholesterol contents by 4-13.56%, blood glucose 14.5%, triglycerides 4.85%, and lowdensity lipoprotein by 9.05% (He et al., 1995;Wieslander et al., 2011;Zhang, Zhang, Lu, Tong, & Cao, 2007). The lipid-lowering activity of buckwheat proteins is linked with their ability to stimulate the bile acid secretions (Kayashita et al., 1997). ...
Article
Consumers are becoming more conscious to adopt a healthy lifestyle and demand highly nutritious foods. Pseudocereals have exceptional nutritional as well as a phytochemical profile with good quality proteins. Due to the lack of gluten, these grains can be incorporated in the diet of people suffering from celiac disease. Celiac disease is a chronic autoimmune disorder affecting the small intestine of people with genetic susceptibility to gluten-containing cereals. Recent studies have concluded that dietary fibers, vitamins, minerals, phenolics, and other bioactives existing in pseudocereals have the potential to combat chronic ailments such as cancer, diabetes, hypertension, and cardiovascular diseases. Due to the presence of bioactives in pseudocereals, these have wide potential to be incorporated in various processed functional foods. Therefore, the commercialization of pseudocereals incorporated functional foods would be helpful not only to celiac patients but also for individuals suffering from numerous lifestyle diseases. Several studies have reported that there is an increasing interest in research and development activities to explore these neglected crops. There is an urgent need to develop a multidisciplinary approach that involves many stakeholders to review and accelerate the domestication of these crops. This review aims at the exploration of nutritional quality, bioactive potential, processing aspects, and health benefits of these underutilized but nutritious grains.
Article
Background: As a potential selenium-enriched crop, it is of great significance to study the selenium application of Tartary buckwheat. Therefore, to study the effects of selenium application concentration, variety, selenium application period and method on the grain selenium content and yield of Tartary buckwheat, an orthogonal experimental design was used to carry out field experiments in the Jinzhong and Northwest Shanxi ecological regions at the same time. Heifeng 1 and Jinqiao 2 were applied at the branching stage and flowering stage in the Jinzhong, and Heifeng 1 and Jinqiao 6 were applied at the early flowering stage and peak flowering stage in the Northwest Shanxi with different concentrations of sodium selenium (0, 1.37, 2.74, 5.48, 8.22, 12.33, 18.495, 27.7425 g hm-2 ) by foliar spraying and soil application. Results: The results showed that the selenium content in Tartary buckwheat grains was positively correlated with the selenium application concentration and increased with increasing selenium application concentration, while the yield of Tartary buckwheat first increased and then decreased with the selenium application concentration. The grain selenium content and yield of Tartary buckwheat were affected by the selenium application concentration, variety and application method. Conclusion: The most effective selenium biofortification program was spraying 2.32 g hm-2 sodium selenite on the leaves of Heifeng 1 at the early flowering stage in the Jinzhong. In the Northwest Shanxi, spraying 11.01 g hm-2 sodium selenite on the leaves of Jinqiao 6 at the flowering stage was the most effective selenium biofortification program. This article is protected by copyright. All rights reserved.
Book
Full-text available
In the recent past, cultivation of traditional crops has been replaced by cash crops and as a result many old varieties of food grains are disappearing. As a result, the age old wisdom of mixed farming that ensured ecological and food security has vanished. Climate variability is also posing serious challenge in the hill State because of the dependence of the regional economy on climate sensitive natural resources. The occurrence of numerous climatic stresses is increasing with each passing year and is posing threat to sustenance of agriculture as a profession. In Himachal Pradesh, farmers mostly rely on rainfed agriculture for their livelihood making them more vulnerable to biotic and abiotic stresses. The State is looking at the hidden potential of rainfed areas to support future food and nutritional security to the growing population. Traditional crops possess more endurance to moisture stress and nutrient deficient conditions prevalent in the mountain ecosystem. These are rich source of energy, protein, micronutrients, and essential amino acids and have hypoglycaemic effects because of high level of dietary fibre. In order to propagate and promote the traditional foodgrain crops in Himachal Pradesh, the State Centre on Climate Change and the H.P. State Biodiversity Board (HPSBB) of the H.P. Council for Science Technology & Environment (HIMCOSTE) made an attempt to compile the information on millets, pseudo cereals, pulses and oil crops which are grown traditionally in State. This information has been compiled in the form of a Coffee Table Book from different sources depicting their ethnobotanical, medicinal, nutritional features and their distribution so that the masses are made aware about the value of these crops.
Article
Hypertension and diabetes mellitus are interrelated diseases that, if untreated, strongly predispose to atherosclerotic cardiovascular disease and renal disease. More than 3 million Americans have both hypertension and diabetes, which are particularly prevalent in the socioeconomically disadvantaged. Hypertension contributes substantially to morbidity and mortality in people with diabetes. This report is an update of the 1987 working group report on hypertension and diabetes and includes important new information on the management of hypertension in people with diabetes. Although treatment of hypertension in most people with diabetes does not differ from that in people who do not have diabetes, this report outlines some special considerations relevant to the presence of both diseases. Lifestyle modification is considered as an initial treatment modality or as an adjunct to pharmacologic measures. This report also includes a discussion of the treatment of hypertension and diabetes in children, an expanded review of sexual dysfunction, and an increased emphasis on the effect of hypertension and diabetes on target organs. A treatment algorithm represents a practical guideline for the physician. Since the previous report, there has been an increased awareness, through clinical trials and pharmacologic research, of the importance of flexibility in the use of antihypertensive drugs as well as a refinement of nonpharmacologic approaches in treating people with both hypertension and diabetes.
Article
The Hypertension Detection and Follow-up Program (HDFP) previously described a significant reduction in five-year, all-cause mortality in its intensively treated stepped care (SC) group relative to its referred care (RC) control group. At the time this finding was described, a proportion of the SC cohort had been treated for periods as long as 6.7 years, but comparable RC and SC mortality data beyond five years were not available. These data, which are described herein, indicate that the 6.7-year life-table mortality rates were 95.1/1000 participants for SC vs 116.3/1000 participants for RC, a larger mortality difference than was observed at five years. This favorable finding for SC extended to all major subgroups, including white women and those aged 30 to 49 years at trial entry. Six months after the close of the treatment trial, a two-year posttrial surveillance study, which extended mortality follow-up to 8.3 years, was conducted. The posttrial use of antihypertensive medication declined in SC and increased in RC participants so that by the end of the posttrial period, there was little difference in the percentages of SC and RC participants taking medication. Control of blood pressure, indicated by mean diastolic blood pressure and by percent of participants with a pressure of 90 mm Hg or less, was slightly better for SC than for RC participants (SC group, 86.5 mm Hg and 68% controlled; RC group, 87.8 mm Hg and 62% controlled). The absolute mortality advantage found at 6.7 years persisted and increased throughout the posttrial period of follow-up despite discontinuation of the formal SC therapy program. It is postulated that regression of hypertensive end-organ changes brought about by the more effective SC treatment caused this favorable outcome. (JAMA 1988;259:2113-2122)
Article
MANY CLINICIANS consider a sufficiently high risk of stroke to be the clearest indication for pharmacological therapy of patients with mild to moderate hypertension. The rationale is derived from several recent overviews or meta-analyses of data from randomized trials. For stroke, there are clear reductions of about 40%, whereas for coronary heart disease (CHD), there are possible reductions of 9% to 14%.1-3 In those trials, the magnitude of the reduction in diastolic blood pressure (DBP) was 5 to 6 mm Hg, and the duration of treatment was about 3 to 5 years. In observational studies, such changes in DBP over longer periods are associated with about a 40% decrease in stroke but 20% to 25% reductions in risk of CHD.3,4 Several possible explanations have been offered for the smaller risk reductions in CHD observed in trials than predicted in observational studies. First, the beneficial effects on stroke may
Article
Oat cereals rich in the water-soluble fiber β-glucan have been studied as a dietary therapy for hypercholesterolemia. To determine the hypocholesterolemic response of β-glucan in the diet, 156 adults with low-density lipoprotein cholesterol (LDL-C) levels above 4.14 mmol/L (160 mg/dL) or between 3.37 and 4.14 mmol/L (130 and 160 mg/dL) with multiple risk factors were randomized to one of seven groups. Six groups received either oatmeal or oat bran at doses (dry weight) of 28 g (1 oz), 56 g (2 oz), and 84 g (3 oz). A seventh group received 28 g of farina (β-glucan control). At week 6 of treatment, significant differences were found for both total cholesterol and LDL-C levels among the farina control and the treatment groups who were receiving 84 g of oatmeal, 56 g of oat bran, and 84 g of oat bran, with decreases in LDL-C levels of 10.1%, 15.9%, and 11.5%, respectively. Fifty-six grams of oat bran resulted in significantly greater reductions in LDL-C levels than 56 g of oatmeal. Nutrient analysis shows no difference in dietary fat content between these treatment groups; therefore, the higher β-glucan content of oat bran most likely explains the significantly greater LDL-C reductions. A dose-dependent reduction in LDL-C levels with oat cereals supports the independent hypocholesterolemic effects of β-glucan. (JAMA. 1991;265:1833-1839)
Article
The purpose of this study was to confirm and extend previous findings that serum cholesterol response to a fat-modified diet is enhanced by oat fiber. Participants (n = 236) were recruited from the Continental Illinois National Bank in Chicago. Data including weight, serum lipid level, lipoproteins, and 3-day food records were collected at baseline and every 4 weeks for 12 weeks. All participants were instructed to follow the fat-modified (Phase II) diet recommended by the American Heart Association (AHA). After 4 weeks, participants were randomly assigned to one of two groups. While both groups continued to follow the AHA diet, Group 1 was instructed to include 2 oz (56 g, dry wt) of oatmeal, isocalorically substituted for other carbohydrate foods. Group 2 served as the control and consumed no oat products throughout the study. Serum cholesterol values at baseline and after 4 weeks of the AHA diet were similar for both groups (203.9 and 193.0 mg/dl for Group 1 and 205.3 and 194.5 mg/dl for Group 2). After 4 weeks of oatmeal intervention, mean group differences were −6.8 and −2.1 mg/dl (P = 0.008 one-tailed t test) for Groups 1 and 2, respectively. Following an additional 4 weeks of oatmeal intervention, the Group 1 mean cholesterol increased slightly (0.9 mg/dl), while the Group 2 level decreased slightly (−0.7 mg/dl). Overall serum cholesterol responses for the two groups from Visit 2 to Visit 4 were −6.0 and −2.8 mg/dl for Groups 1 and 2, respectively (P = 0.074, one tail). Changes in weight were small and nonsignificant. Subgroup analyses revealed greater reductions in serum cholesterol among participants with the highest baseline serum cholesterol (−8.0 mg/dl vs −1.7 mg/dl for Subgroups 1 and 2, respectively). These data support previous findings that inclusion of oatmeal in a fat-modified diet is helpful in lowering serum cholesterol, particularly for individuals with elevated serum cholesterol levels.
Article
Lipid and lipoprotein values, including fasting triglycerides and high density lipoproteins (HDL), low density lipoproteins (LDL) and total cholesterol levels, were obtained on 2,815 men and women aged 49 to 82 years chiefly between 1969 and 1971 at Framingham. In the approximately four years following the characterization of lipids, coronary heart disease developed in 79 of the 1,025 men and 63 of the 1,445 women free of coronary heart diseases. At these older ages the major potent lipid risk factor was HDL cholesterol, which had an inverse association with the incidence of coronary heart disease (p less than 0.001) in either men or women. This lipid was associated with each major manifestation of coronary heart disease. These associations were equally significant even when other lipids and other standard risk factors for coronary heart disease were taken into consideration. A weaker association with the incidence of coronary heart disease (p less than 0.05) was observed for LDL cholesterol. Triglycerides were associated with the incidence of coronary heart disease only in women and then only when the level of other lipids was not taken into account. At these ages total cholesterol was not associated with the risk of coronary heart disease.